2. Beighton P, Hamersma, Horan F. Craniometaphyseal dysplasia: variability of expression within a large family. Clin Genet 1979;15:252-8. 3. Gorlin R J, Spranger J, Koszalka MF. Genetic craniotubular bone dysplasia and hypertoses: a critical analysis. Birth Defects 1969;4:79-95. 4. Rimoin DL, Woodruff SL, Holman BL. Craniometaphyseal dysplasia (Pyle's disease): autosomal dominant inheritance in a large kindred. Birth Defects 1969;4:299-303. 5. Conway HN, Anast CS. Double-antibody radioimmunoassay for parathyroid hormone. J Lab Clin Med 1974;83:129-38. 6. Prockop D J, Udenfriend A. A specific method for the analysis of hydroxyproline in tissues and urine. Anal Biochem 1960;1:228-39. 7. Annino JS. Clinical chemistry: principles and procedures, 3rd ed. Boston: Little; Brown, 1964:248-51. 8. Baron R, Gertner GM, Lang R, Vignery A. Increased bone turnover with decreased bone formation by osteoblasts in children with osteogenesis imperfecta. Pediatr Res 1983; 17:204-7. 9. Key L, Carnes D, Holtrop M, et al. Treatment of congenital oste0petrosis with high dose calcitriol. N Engl J Med 1984; 310:409-15. 10. Beighton P, Horan F, Hamersma H. A review of osteopetroses. Postgrad Med J 1977;53:507-15. 11. Penchaszadeh VB, Gutierrez ER, Figueroa EP. Autosomal recessive craniometaphyseal dysplasia. Am J Med Genet 1980;5:43-55. 12. Schwarz, E. Craniometaphyseal dysplasia. A JR 1960;84:4616. 13. Girdwood TG, Gibson WJA, Mackintosh TF. Craniometaphyseal dysplasia: congenital Pyle's disease in a young child. Br J Radiol 1969;42:299-303. 14. Halliday J. A rare case of bone dystrophy. Br J Surg 1949; 37:52-63. 15. Norman AW. Vitamin D: the calcium hosmeostatic steroid hormone. New York: Academic Press, 1977. 16. Aarskog D, Aksnes L, Markestad T. Effect of parathyroid hormone on vitamin D metabolism in osteopetrosis. Pediatrics 1981i68:109-12.
Read full abstract